Brok, D. den
1895  results:
Search for persons X
?
2

Risk factors associated with nausea and vomiting in childre..:

Eliasen, Astrid ; Kornholt, J ; Mathiasen, R...
Journal of Oncology Pharmacy Practice.  29 (2022)  6 - p. 1361-1368 , 2022
 
?
5

Antenatal magnesium sulphate for the prevention of cerebral..:

Wolf, HT ; Brok, J ; Henriksen, TB...
BJOG: An International Journal of Obstetrics & Gynaecology.  127 (2020)  10 - p. 1217-1225 , 2020
 
?
6

Magnesium sulphate for fetal neuroprotection at imminent ri..:

Wolf, HT ; Huusom, LD ; Henriksen, TB...
BJOG: An International Journal of Obstetrics & Gynaecology.  127 (2020)  10 - p. 1180-1188 , 2020
 
?
7

Antenatal magnesium sulphate to prevent cerebral palsy in v..:

Brok, J ; Huusom, LD ; Secher, NJ...
BJOG: An International Journal of Obstetrics & Gynaecology.  118 (2011)  7 - p. 892-893 , 2011
 
?
8

The information gap between the required and the actual acc..:

Brok, J ; Huusom, LD ; Secher, NJ...
BJOG: An International Journal of Obstetrics & Gynaecology.  118 (2011)  7 - p. 891-891 , 2011
 
?
9

Monitoring patients at risk of massive transfusion with Thr..:

WIKKELSOE, A. J. ; AFSHARI, A. ; WETTERSLEV, J...
Acta Anaesthesiologica Scandinavica.  55 (2011)  10 - p. 1174-1189 , 2011
 
?
10

Antenatal magnesium sulphate may prevent cerebral palsy in ..:

Huusom, LD ; Secher, NJ ; Pryds, O...
BJOG: An International Journal of Obstetrics & Gynaecology.  118 (2010)  1 - p. 1-5 , 2010
 
?
11

Meta‐analysis: ribavirin plus interferon vs. interferon mon..:

Brok, J. ; Gluud, L.‐L. ; Gluud, C.
Alimentary Pharmacology & Therapeutics.  32 (2010)  7 - p. 840-850 , 2010
 
?
12

Cochrane systematic review: pegylated interferon plus ribav..:

SIMIN, M. ; BROK, J. ; STIMAC, D...
Alimentary Pharmacology & Therapeutics.  25 (2007)  10 - p. 1153-1162 , 2007
 
?
15

The contribution of the recurrent laryngeal nerve in the mo..:

Brok ; Stroeve ; Copper..
Clinical Otolaryngology and Allied Sciences.  23 (1998)  4 - p. 377-377 , 1998
 
1-15